Learn how acid reflux may be making your IPF worse, and how you can manage it.

David Zhang, MD, discusses the limitations of polygenic risk scores and remaining barriers to their clinical use in idiopathic pulmonary fibrosis. Polygenic risk scores (PRS) may serve as an important ...

IPF patients showed reduced anxiety and depression scores one month post-COVID-19 vaccination, indicating improved mental health. The study emphasized the heightened COVID-19 risk for IPF patients, ...

If you have idiopathic pulmonary fibrosis (IPF), a chronic lung condition that can cause shortness of breath, low oxygen levels in the blood, and scarring on the lungs (fibrosis), it’s important to ...

Boehringer Ingelheim’s Jascayd receives European marketing approval to treat adults with IPF & progressive pulmonary fibrosis: Ingelheim, Germany Saturday, July 18, 2026, 15:00 ...

United Therapeutics UTHR remains poised to expand Tyvaso’s label in the respiratory disease space. It recently unveiled results from the late-stage TETON-2 study, which showed clinical benefit in ...

Idiopathic pulmonary fibrosis (IPF) is a serious lung condition involving scar tissue inside your lungs that makes it hard to breathe. It is a progressive condition, which means that it gets worse ...

Celea Therapeutics begins patient dosing in global phase 3 SURPASS-IPF trial of deupirfenidone to treat idiopathic pulmonary fibrosis: Boston Tuesday, July 14, 2026, 16:00 Hrs [IS ...